35 Episoade

  1. Episode 14: A Quantum Leap in AML Treatment? Dissecting Quizartinib Data with Dr. Dale Bixby

    Publicat: 09.05.2023

  2. Episode 13: You get blinatumomab! You get blinatumomab!

    Publicat: 24.02.2023

  3. Episode 12: Tinder for T Cells - Bispecifics in DLBCL

    Publicat: 08.02.2023

  4. Episode 11: "Olu the Drunk Snowman" - IDH inhibitors in R/R AML with Dr. Jill Lykon

    Publicat: 21.01.2023

  5. Episode 10: ASH Recap Part 2 - Papa Heme + WolverHeme

    Publicat: 21.12.2022

  6. Episode 9: ASH Recap Part 1 - Dauno-Double Trouble

    Publicat: 14.12.2022

  7. Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with Dr. Dale Bixby

    Publicat: 23.11.2022

  8. Episode (3+)7: Straight Outta Roswell - OG AML Data

    Publicat: 07.10.2022

  9. Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Asparaginase

    Publicat: 21.07.2022

  10. Episode 5: IDH Inhibitors in AML: not so AGILE

    Publicat: 03.06.2022

  11. Episode 4: All Aboard the Oncology StewardSHIP

    Publicat: 27.05.2022

  12. Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia

    Publicat: 22.04.2022

  13. Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone

    Publicat: 22.04.2022

  14. Episode 2: We Don't Talk About Rylaze

    Publicat: 18.03.2022

  15. Episode 1: Surrogate Endpoints in AML

    Publicat: 11.03.2022

2 / 2

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Visit the podcast's native language site